9th Translational Research Conference on Lymphoid Malignancies
Oct. 21-23, 2027/Dubrovnik, Croatia
Chairs: Michael Hallek, Thomas Oellerich, Laurie Sehn, Louis Staudt, Catherine Wu
For more info ➡ bit.ly/4vvBEBb
#ESHCONFERENCES #Lmsm #CLLsm
9th Translational Research Conference on Lymphoid Malignancies
Oct. 21-23, 2027/Dubrovnik, Croatia
Chairs: Michael Hallek, Thomas Oellerich, Laurie Sehn, Louis Staudt, Catherine Wu
For more info ➡ bit.ly/4vvBEBb
#ESHCONFERENCES #Lmsm #CLLsm
Learn more: LymphomaHub.com
#CLLsm #leusm #MedNews #MedEd
Fixed-duration VO 1L CLL: clinically sig⬆️in global QoL that improves after tx completion, regardless of age or TP53/IGHV status. Fatigue & CLL sx burden also improve. Great RW data for pt counseling with common 1L #cllsm regimen. #lymsm #ASH25 @ash.hematology.org
Fixed-duration VO 1L CLL: clinically sig⬆️in global QoL that improves after tx completion, regardless of age or TP53/IGHV status. Fatigue & CLL sx burden also improve. Great RW data for pt counseling with common 1L #cllsm regimen. #lymsm #ASH25 @ash.hematology.org
Watch here:
👉 buff.ly/FZdouqO 👈
#CLLsm #Leusm #Leukemia #HemOnc #BloodSky #HemeSky #MedSky
Watch here:
👉 buff.ly/FZdouqO 👈
#CLLsm #Leusm #Leukemia #HemOnc #BloodSky #HemeSky #MedSky
👉 buff.ly/BKMPQGT 👈
#CLLsm #Leusm #Leukemia #HemOnc #iwCLL2025 #BloodSky #HemeSky #MedSky
👉 buff.ly/BKMPQGT 👈
#CLLsm #Leusm #Leukemia #HemOnc #iwCLL2025 #BloodSky #HemeSky #MedSky
We recently had the pleasure of speaking to Helen Parry to find out more about the study:
🎥 buff.ly/j1K0VV8
#CLLsm #Leusm #Leukemia #CTSM #iwCLL2025 #ImmunoOnc
We recently had the pleasure of speaking to Helen Parry to find out more about the study:
🎥 buff.ly/j1K0VV8
#CLLsm #Leusm #Leukemia #CTSM #iwCLL2025 #ImmunoOnc
👉 buff.ly/paPH5vx 👈
#CLLsm #iwCLL2025 #Leusm #CTSM #BloodSky #HemeSky
👉 buff.ly/paPH5vx 👈
#CLLsm #iwCLL2025 #Leusm #CTSM #BloodSky #HemeSky
Watch the interview here:
🎥 buff.ly/sZGLLe2
#CLLsm #Leusm #Leukemia #HemOnc #BloodSky #HemeSky #MedSky
Watch the interview here:
🎥 buff.ly/sZGLLe2
#CLLsm #Leusm #Leukemia #HemOnc #BloodSky #HemeSky #MedSky
Jacob Soumerai discussed this in a recent interview:
🎥 buff.ly/6qCplqB
#CLLsm #Leusm #iwCLL2025 #HemOnc #BloodSky #HemeSky #MedSky
Jacob Soumerai discussed this in a recent interview:
🎥 buff.ly/6qCplqB
#CLLsm #Leusm #iwCLL2025 #HemOnc #BloodSky #HemeSky #MedSky
👉 buff.ly/BiuqDZd 👈
#CLLsm #Leusm #Leukemia #HemOnc #iwCLL2025 #BloodSky #HemeSky #MedSky
👉 buff.ly/BiuqDZd 👈
#CLLsm #Leusm #Leukemia #HemOnc #iwCLL2025 #BloodSky #HemeSky #MedSky
Watch the interview here:
👉 buff.ly/UvDvXD3 👈
#CLLsm #Leusm #CTSM #TrialUpdate #BloodSky #HemeSky #MedSky
Watch the interview here:
👉 buff.ly/UvDvXD3 👈
#CLLsm #Leusm #CTSM #TrialUpdate #BloodSky #HemeSky #MedSky
👉 buff.ly/Rs2rluB 👈
#iwCLL2025 #CLLsm #Leusm #Leukemia #HemOnc #MedSky
👉 buff.ly/Rs2rluB 👈
#iwCLL2025 #CLLsm #Leusm #Leukemia #HemOnc #MedSky
👉 buff.ly/rBWUBYh 👈
#iwCLL2025 #CLLsm #Leusm #CTSM #TrialUpdate #BloodSky #HemeSky
👉 buff.ly/rBWUBYh 👈
#iwCLL2025 #CLLsm #Leusm #CTSM #TrialUpdate #BloodSky #HemeSky
Click here to check out the interview:
🎥 buff.ly/20uHc4O
#CLLsm #Leusm #iwCLL2025 #Leukemia #HemOnc #BloodSky #MedSky
Click here to check out the interview:
🎥 buff.ly/20uHc4O
#CLLsm #Leusm #iwCLL2025 #Leukemia #HemOnc #BloodSky #MedSky
Watch our interview with Britten Gordon from #iwCLL2025:
🎥 buff.ly/eKQamE2
#CLLsm #Leusm #Leukemia #HemOnc #MedSky #BloodSky #HemeSky
Watch our interview with Britten Gordon from #iwCLL2025:
🎥 buff.ly/eKQamE2
#CLLsm #Leusm #Leukemia #HemOnc #MedSky #BloodSky #HemeSky
Then make sure you watch our interview from #iwCLL2025 with Nil Albiol of @hospitalclinic.bsky.social:
🎥 buff.ly/AnTQebz
#CARTCell #ImmunoOnc #CLLsm #Leusm
Then make sure you watch our interview from #iwCLL2025 with Nil Albiol of @hospitalclinic.bsky.social:
🎥 buff.ly/AnTQebz
#CARTCell #ImmunoOnc #CLLsm #Leusm
Not to worry! Check out our exclusive coverage of the meeting to catch up on the latest updates and advances in CLL:
👉 buff.ly/GBOkgBn 👈
#CLLsm #Leusm #Leukemia #HemOnc #CTSM #ImmunoOnc
Not to worry! Check out our exclusive coverage of the meeting to catch up on the latest updates and advances in CLL:
👉 buff.ly/GBOkgBn 👈
#CLLsm #Leusm #Leukemia #HemOnc #CTSM #ImmunoOnc
Hear as Dr Davids introduces the MAVRiC trial, which will investigate a mutation-guided retreatment strategy using the AV regimen in patients with CLL/SLL in the 2L setting:
👉 buff.ly/aouDK9h
#CLLsm
Hear as Dr Davids introduces the MAVRiC trial, which will investigate a mutation-guided retreatment strategy using the AV regimen in patients with CLL/SLL in the 2L setting:
👉 buff.ly/aouDK9h
#CLLsm
👉 buff.ly/aDN40ud 👈
#CLLsm #Leusm #Leukemia #HemOnc #MantleCellLymphoma #LYMsm #HemeSky #BloodSky
👉 buff.ly/aDN40ud 👈
#CLLsm #Leusm #Leukemia #HemOnc #MantleCellLymphoma #LYMsm #HemeSky #BloodSky
Watch the interview here:
🎥 buff.ly/ZwOkLWw
#CLLsm #Leusm #Leukemia #HemOnc
Watch the interview here:
🎥 buff.ly/ZwOkLWw
#CLLsm #Leusm #Leukemia #HemOnc
Thank you to the organizers for having us on-site, and to the experts who interviewed with us!😊
Check out our exclusive coverage of the event here, with more coming soon:
👉 buff.ly/Fv2j8p4
#CLLsm #Leusm #Leukemia #HemOnc
Thank you to the organizers for having us on-site, and to the experts who interviewed with us!😊
Check out our exclusive coverage of the event here, with more coming soon:
👉 buff.ly/Fv2j8p4
#CLLsm #Leusm #Leukemia #HemOnc
Keep an eye on our site over the coming weeks for our exclusive coverage from the event.🎥
👉VJHemOnc.com
#CLLsm #Leusm #Leukemia #BloodSky #MedSky #HemeSky #HemOnc
Dive into our disease channels for the latest news & updates in AML, ALL, CLL, CML, & more: 👉 buff.ly/PCXVECQ
Video interviews, podcasts, roundtable discussions, articles – we have it all! 🎥 🗞️ 🎧
#AMLsm #CLLsm #ALLsm #Leusm
Dive into our disease channels for the latest news & updates in AML, ALL, CLL, CML, & more: 👉 buff.ly/PCXVECQ
Video interviews, podcasts, roundtable discussions, articles – we have it all! 🎥 🗞️ 🎧
#AMLsm #CLLsm #ALLsm #Leusm
Learn more in our interview with the lovely Jennifer Crombie of @danafarber.bsky.social:
🎥 buff.ly/GzIwSol
#CLLsm #Leusm #Leukemia #CTSM #TrialUpdate #HemOnc
Learn more in our interview with the lovely Jennifer Crombie of @danafarber.bsky.social:
🎥 buff.ly/GzIwSol
#CLLsm #Leusm #Leukemia #CTSM #TrialUpdate #HemOnc
At #18ICML, Dr Davids shared insights into the ReVenG trial, evaluating the safety & efficacy of venetoclax plus obinutuzumab retreatment in R/R CLL.
Watch now:
👉 buff.ly/5rzmgND 👈
#CLLsm #Leusm #Leukemia
At #18ICML, Dr Davids shared insights into the ReVenG trial, evaluating the safety & efficacy of venetoclax plus obinutuzumab retreatment in R/R CLL.
Watch now:
👉 buff.ly/5rzmgND 👈
#CLLsm #Leusm #Leukemia